Chemical compounds designed to enhance understanding of host-pathogen interaction together with next-generation 'smart drugs' will rationally drive the discovery of promising new host-directed targets against pathogens including Mycobacterium tuberculosis, the causative agent of tuberculosis.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Chemical p38 MAP kinase inhibition constrains tissue inflammation and improves antibiotic activity in Mycobacterium tuberculosis-infected mice
Scientific Reports Open Access 12 August 2020
-
Corticosteroids inhibit Mycobacterium tuberculosis-induced necrotic host cell death by abrogating mitochondrial membrane permeability transition
Nature Communications Open Access 08 February 2019
-
CD82 hypomethylation is essential for tuberculosis pathogenesis via regulation of RUNX1-Rab5/22
Experimental & Molecular Medicine Open Access 14 May 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gatfield, J. & Pieters, J. Science 288, 1647–1650 (2000).
Houben, D. et al. Cell. Microbiol. 14, 1287–1298 (2012).
Wang, J. et al. Nat. Immunol. 16, 237–245 (2015).
Li, J. et al. J. Immunol. 194, 3756–3767 (2015).
Ng, V.H., Cox, J.S., Sousa, A.O., MacMicking, J.D. & McKinney, J.D. Mol. Microbiol. 52, 1291–1302 (2004).
Maloney, E. et al. PLoS Pathog. 5, e1000534 (2009).
Kim, K.H et al. Proc. Natl. Acad. Sci. USA 109, 7729–7734 (2012).
Pennini, M.E., Pai, R.K., Schultz, D.C., Boom, W.H. & Harding, C.V. J. Immunol. 176, 4323–4330 (2006).
Wallis, R.S. & Hafner, R. Nat. Rev. Immunol. 15, 255–263 (2015).
Hawn, T.R., Shah, J.A. & Kalman, D. Immunol. Rev. 264, 344–362 (2015).
Peyron, P. et al. PLoS Pathog. 4, e1000204 (2008).
Liappis, A.P., Kan, V.L., Rochester, C.G. & Simon, G.L. Clin. Infect. Dis. 33, 1352–1357 (2001).
Parihar, S.P. et al. J. Infect. Dis. 209, 754–763 (2014).
Parihar, S.P. et al. PLoS ONE 8, e75490 (2013).
Singhal, A. et al. Sci. Transl. Med. 6, 263ra159 (2014).
Sharma, G., Upadhyay, S., Srilalitha, M., Nandicoori, V.K. & Khosla, S. Nucleic Acids Res. 43, 3922–3937 (2015).
Yi, Z., Fu, Y., Ji, R., Li, R. & Guan, Z. PLoS ONE 7, e43184 (2012).
Iannaccone, M., Dorhoi, A. & Kaufmann, S.H. Expert Opin. Ther. Targets 18, 491–494 (2014).
Yu, A.D., Wang, Z. & Morris, K.V. Immunol. Cell Biol. 93, 277–283 (2015).
Barichievy, S., Naidoo, J. & Mhlanga, M.M. Front. Genet. 6, 108 (2015).
Forrest, A.R. et al. Nature 507, 462–470 (2014).
Arner, E. et al. Science 347, 1010–1014 (2015).
Roy, S. et al. Nucleic Acids Res. 43, 6969–6982 (2015).
Acknowledgements
We thank M. Ozturk and O. Tamgue for critical reading of the manuscript. This work was supported by a National Research Foundation (NRF) of South Africa grant and by the Department of Science and Technology (DST), South African Research Chair Initiative, South African Medical Research Council (SAMRC), the NRF Competitive Programme for Unrated Researchers, DST/NRF Collaborative Postgraduate Training Programme and SAMRC Self-initiated Research Grant.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Guler, R., Brombacher, F. Host-directed drug therapy for tuberculosis. Nat Chem Biol 11, 748–751 (2015). https://doi.org/10.1038/nchembio.1917
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio.1917
This article is cited by
-
Chemical p38 MAP kinase inhibition constrains tissue inflammation and improves antibiotic activity in Mycobacterium tuberculosis-infected mice
Scientific Reports (2020)
-
Corticosteroids inhibit Mycobacterium tuberculosis-induced necrotic host cell death by abrogating mitochondrial membrane permeability transition
Nature Communications (2019)
-
Mycobacterium Tuberculosis and Interactions with the Host Immune System: Opportunities for Nanoparticle Based Immunotherapeutics and Vaccines
Pharmaceutical Research (2019)
-
Combined chemical genetics and data-driven bioinformatics approach identifies receptor tyrosine kinase inhibitors as host-directed antimicrobials
Nature Communications (2018)
-
CD82 hypomethylation is essential for tuberculosis pathogenesis via regulation of RUNX1-Rab5/22
Experimental & Molecular Medicine (2018)